JP2012512157A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012512157A5 JP2012512157A5 JP2011540796A JP2011540796A JP2012512157A5 JP 2012512157 A5 JP2012512157 A5 JP 2012512157A5 JP 2011540796 A JP2011540796 A JP 2011540796A JP 2011540796 A JP2011540796 A JP 2011540796A JP 2012512157 A5 JP2012512157 A5 JP 2012512157A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- medicament
- class
- selective hdac
- enzastaurine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12245108P | 2008-12-15 | 2008-12-15 | |
| US61/122,451 | 2008-12-15 | ||
| PCT/US2009/066925 WO2010074936A2 (en) | 2008-12-15 | 2009-12-07 | Enzastaurin for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012512157A JP2012512157A (ja) | 2012-05-31 |
| JP2012512157A5 true JP2012512157A5 (https=) | 2012-08-23 |
Family
ID=41785627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540796A Withdrawn JP2012512157A (ja) | 2008-12-15 | 2009-12-07 | 癌を治療するためのエンザスタウリン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110288032A1 (https=) |
| EP (1) | EP2376081A2 (https=) |
| JP (1) | JP2012512157A (https=) |
| KR (1) | KR20110084533A (https=) |
| CN (1) | CN102245184A (https=) |
| AU (1) | AU2009330492A1 (https=) |
| BR (1) | BRPI0922367A2 (https=) |
| CA (1) | CA2746085A1 (https=) |
| EA (1) | EA201170821A1 (https=) |
| MX (1) | MX2011006433A (https=) |
| WO (1) | WO2010074936A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3007787C (en) | 2010-06-03 | 2020-03-10 | Pharmacyclics Llc | The use of inhibitors of bruton's tyrosine kinase (btk) |
| CA2862492A1 (en) * | 2012-01-24 | 2013-08-01 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| EP2812338A4 (en) * | 2012-01-24 | 2015-09-23 | Millennium Pharm Inc | METHOD FOR THE TREATMENT OF NASOPHARYNGEAL CANCER |
| AU2013221298A1 (en) * | 2012-02-17 | 2014-08-28 | Pharmacyclics Llc | Combinations of histone deacetylase inhibitor and pazopanib and uses thereof |
| CN104704129A (zh) | 2012-07-24 | 2015-06-10 | 药品循环公司 | 与对布鲁顿酪氨酸激酶(btk)抑制剂的抗性相关的突变 |
| MX372671B (es) * | 2013-07-19 | 2020-04-23 | Onyx Therapeutics Inc | Inhibidores de proteasoma de epoxicetona peptídica en combinacion con inhibidores de cinasa pim para el tratamiento de canceres. |
| US9885086B2 (en) | 2014-03-20 | 2018-02-06 | Pharmacyclics Llc | Phospholipase C gamma 2 and resistance associated mutations |
| WO2017011314A1 (en) * | 2015-07-10 | 2017-01-19 | Paharmacyclics Llc | Btk and hdac combinations |
| EP3963092A1 (en) * | 2019-05-02 | 2022-03-09 | Predictive Technology Group, Inc. | Somatic cancer driver mutations in endometriosis lesions contribute to secondary cancer risk |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2179650C (en) | 1993-12-23 | 2007-10-30 | William Francis Heath, Jr. | Bisindolemaleimides and their use as protein kinase c inhibitors |
| US20080096923A1 (en) * | 2004-07-23 | 2008-04-24 | Aniz Girach | Methods For Diagnosing And Treating Diabetic Microvascular Complications |
| WO2006135733A2 (en) * | 2005-06-10 | 2006-12-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Modulation of peripheral clocks in adipose tissue |
-
2009
- 2009-12-07 KR KR1020117013612A patent/KR20110084533A/ko not_active Ceased
- 2009-12-07 WO PCT/US2009/066925 patent/WO2010074936A2/en not_active Ceased
- 2009-12-07 BR BRPI0922367A patent/BRPI0922367A2/pt not_active IP Right Cessation
- 2009-12-07 JP JP2011540796A patent/JP2012512157A/ja not_active Withdrawn
- 2009-12-07 CN CN2009801503024A patent/CN102245184A/zh active Pending
- 2009-12-07 CA CA2746085A patent/CA2746085A1/en not_active Abandoned
- 2009-12-07 MX MX2011006433A patent/MX2011006433A/es not_active Application Discontinuation
- 2009-12-07 EP EP09768467A patent/EP2376081A2/en not_active Withdrawn
- 2009-12-07 EA EA201170821A patent/EA201170821A1/ru unknown
- 2009-12-07 AU AU2009330492A patent/AU2009330492A1/en not_active Abandoned
- 2009-12-07 US US13/130,104 patent/US20110288032A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012512157A5 (https=) | ||
| Mitchell | Gastrointestinal toxicity of chemotherapeutic agents | |
| NZ599464A (en) | Combination therapies using hdac inhibitors | |
| EA201300323A1 (ru) | Материалы и способы улучшения функции желудочно-кишечного тракта | |
| EP3738587A3 (en) | Dosage form for insertion into the mouth | |
| EA200900155A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
| ATE534378T1 (de) | Titrierung von tapentadol | |
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
| EA201290833A1 (ru) | Применение амисульприда в качестве противорвотного средства | |
| DE602007007991D1 (de) | Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung | |
| EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
| EP2395834A4 (en) | Sodium nitrite-containing pharmaceutical compositions | |
| WO2012117257A8 (en) | Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer | |
| EA201100153A1 (ru) | Никотинсодержащие мягкие желатиновые пастилки | |
| EA201000855A1 (ru) | Способ и средства для достижения бронхиальной релаксации | |
| WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
| EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
| ECSP11011314A (es) | Combinaciones farmacéuticas que comprenden rdea119/bay 869766 para el tratamiento de cánceres específicos | |
| CY1117568T1 (el) | Χρηση μιας συνθεσης η οποια περιλαμβανει φορμοτερολη και διπροπιονικη βεκλομεθαζονη για την αγωγη μιας εξαρσης ασθματος | |
| EA201170821A1 (ru) | Энзастаурин для лечения рака | |
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| MX2010004350A (es) | Metodos de uso del acido (+)-1,4-dihidro-7-[(3s,4s)]-3-metoxi-4-(m etilamino)-1-pirrolidinil-4-oxo-1-(2-tiazolil)-1, 8-naftiridina-3-carboxilico en terapias de combinacion. | |
| TNSN08506A1 (en) | Substituted carboxamides | |
| TW200735859A (en) | Methods of treating cancers with SAHA, carboplatin, and paclitaxel and other combination therapies |